Qkine Limited

Qkine Limited

Qkine Limited

Optimised human recombinant Rspondin 1 (Qk006 RSPO1) was developed during a project cofunded by Innovate UK.
Founded
2016
Raised
$696.2k
Follow us
Alexa global traffic share
Twitter followers
Latest funding
Team Size
1–10
Employees
UKTN (UK Tech News)

Qkine secures £1.5m Series A